We also compared PRS for intelligence, longevity, and epilepsy between GEL SCN1A controls and the 13 Dravet syndrome cases with SCN1A missense variants. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.